The emergence of the highly transmissible B.1.1.529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody countermeasure …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …

Neutralizing antibodies against the SARS-CoV-2 spike (S) protein are a goal of COVID-19
vaccines and have received emergency use authorization as therapeutics. However, viral …

Natural killer (NK) cells express inhibitory and activation receptors that recognize MHC class
I-like molecules on target cells. These receptors may be involved in the critical role of NK …

Class I major histocompatibility complex (MHC) molecules interact with self and foreign peptides
of diverse amino acid sequences yet exhibit distinct allele-specific selectivity for peptide …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic
with millions of human infections. One limitation to the evaluation of potential therapies and …

The coronavirus disease 2019 pandemic has made deployment of an effective vaccine a
global health priority. We evaluated the protective activity of a chimpanzee adenovirus-…

The x-ray structures of a murine MHC class I molecule (H-2K b ) were determined in complex
with two different viral peptides, derived from the vesicular stomatitis virus nucleoprotein (52…

Rapidly emerging SARS-CoV-2 variants jeopardize antibody-based countermeasures.
Although cell culture experiments have demonstrated a loss of potency of several anti-spike …

Neutralization of West Nile virus (WNV) in vivo correlates with the development of an antibody
response against the viral envelope (E) protein. Using random mutagenesis and yeast …